Use of PD-1 Inhibitors in the Treatment of Advanced Basal Cell Carcinoma

Dermatol Surg. 2021 Nov 1;47(11):1511-1512. doi: 10.1097/DSS.0000000000003207.

Authors

Nader Aboul-Fettouh¹, Leon Chen^{2

3}, Sirunya Silapunt¹, Michael R Migden⁴

Affiliations

¹ Department of Dermatology, the University of Texas McGovern Medical School at Houston, Houston, Texas.
² US Dermatology Partners, Houston, Texas.
³ Elite Dermatology, Houston, Texas.
⁴ Departments of Dermatology and Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 34699444
DOI: 10.1097/DSS.0000000000003207

No abstract available

Publication types

Review

MeSH terms

Carcinoma, Basal Cell / drug therapy*
Carcinoma, Basal Cell / pathology
Humans
Immune Checkpoint Inhibitors / therapeutic use*
Neoplasm Staging
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Immune Checkpoint Inhibitors